Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Implementing Optimal Guidelines for Growth Hormone Use in a Managed Care Population

Participating Faculty

By

September 1st 2000

Introduction

ByRon Rosenfeld, MD

September 1st 2000

Growth Hormone Use in Pediatric Growth Hormone Deficiency and Other Pediatric Growth Disorders

ByRon Rosenfeld, MD,David B. Allen, MD,Margaret H. MacGillivray, MD,Craig Alter, MD,Paul Saenger, MD,Henry Anhalt, DO,Ray Hintz, MD,Har

September 1st 2000

Clinical and Reimbursement Issues on Growth Hormone Use in Adults

ByBenerly M.K. Biller, MD,Mary Lee Vance, ND,David L. Kleinberg, MD,David M. Cook, MD,Terry Gordon, MD, MBA

September 1st 2000

Growth Hormone Use in Transitioning Patients -- Clinician and Payer Concerns

ByStephen LaFranchi, MD,Margaret H. MacGillivray, MD,Pete Fullerton, PhD

September 1st 2000

Recommendations on Improving the Use of and Managed Care Review Process of Growth Hormone Therapy

By

September 1st 2000

Clinician and Payer Issues in Managing Growth Hormone Deficiency

ByGary M. Owens, MD

September 1st 2000

CME / CPE / CCMCE Quiz

By

September 1st 2000

Selected Abstracts

By

September 1st 2000

Trending on AJMC

West Coast Health Alliance Releases First Vaccine Guidelines, Aiming to Replace CDC Recommendations

Metabolic Issues More Common in Patients With HIV

Iron Dysregulation Linked to MS Progression, Review Finds

Barriers to Gender-Affirming Surgery Persist Despite High Satisfaction Rate

Efficacy of Ruxolitinib Cream in Nonsegmental Vitiligo Confirmed in Real-World Study

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

© 2025 MJH Life Sciences^®

All rights reserved.